Related references
Note: Only part of the references are listed.Polymeric Tubulysin-Peptide Nanoparticles with Potent Antitumor Activity
Thomas Schluep et al.
CLINICAL CANCER RESEARCH (2009)
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design
Steven D. Perrault et al.
NANO LETTERS (2009)
Contribution of linker stability to the activities of anticancer immunoconjugates
Stephen C. Alley et al.
BIOCONJUGATE CHEMISTRY (2008)
Antibody-drug conjugates for cancer therapy
Paul J. Carter et al.
CANCER JOURNAL (2008)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging
Derek W. Bartlett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Preclinical evaluation of EC145, a folate-Vinca alkaloid conjugate
Joseph A. Reddy et al.
CANCER RESEARCH (2007)
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models
Dmitri B. Kirpotin et al.
CANCER RESEARCH (2006)
Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice
T Schluep et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models
T Schluep et al.
CLINICAL CANCER RESEARCH (2006)
Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers
MR Dreher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
Antitumor activity of β-cyclodextrin polymer -: Camptothecin conjugates
Jianjun Cheng et al.
MOLECULAR PHARMACEUTICS (2004)
Cyclodextrin-based pharmaceutics: Past, present and future
ME Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Synthesis of linear, β-cyclodextrin-based polymers and their camptothecin conjugates
JJ Cheng et al.
BIOCONJUGATE CHEMISTRY (2003)
Openings between defective endothelial cells explain tumor vessel leakiness
H Hashizume et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model
A Moore et al.
RADIOLOGY (2000)
Share Paper
